METHYLPREDNISOLONE ACETATE
Generic: METHYLPREDNISOLONE ACETATE
Amneal Pharmaceuticals NY LLCManufacturer
INTRA-ARTICULAR, INTRALESIONAL, INTRAMUSCULAR, INTRASYNOVIAL, SOFT TISSUERoute
METHYLPREDNISOLONE ACETATEActive Substance
2019-05-20Original Approval
METHYLPREDNISOLONE ACETATE is FDA application ANDA210043, sponsored by AMNEAL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2024-02-20
Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in Failed Dissolution Specifications
Class II2024-04-25
MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial, Rx onPresence of Particulate Matter: Potential for black particulates in the drug product.
Top Reported Reactions
1
OFF LABEL USE
1,046 reports
2
PAIN
1,037 reports
3
RHEUMATOID ARTHRITIS
909 reports
4
DRUG INEFFECTIVE
841 reports
5
FATIGUE
785 reports
6
HEADACHE
771 reports
7
HEPATIC ENZYME INCREASED
603 reports
8
JOINT SWELLING
597 reports
9
DRUG HYPERSENSITIVITY
588 reports
10
RASH
586 reports